Lv65
2196 积分 2021-05-31 加入
Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity
8天前
已完结
siRNA and RNAi optimization
23天前
已完结
Structure-based optimization leads to the discovery of NSC765844, a highly potent, less toxic and orally efficacious dual PI3K/mTOR inhibitor
1个月前
已完结
Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis
1个月前
已完结
Systemic Treatments for Chronic Spontaneous Urticaria: Anti-IgE and Beyond
2个月前
已关闭
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models
3个月前
已完结
Discovery of Novel Class of METTL3 Inhibitors with a Pyridin-2(1 H )-one Moiety
3个月前
已完结
siRNA: Mechanism of action, challenges, and therapeutic approaches
3个月前
已完结
N-acetylgalactosamine delivery systems for RNA therapeutics: a patent perspective
3个月前
已完结
siRNA-based delivery systems: Technologies, carriers, applications, and approved products
3个月前
已完结
皖公网安备34019202002308
